Association of ANA and SSA autoantibodies with progression-free survival in multiple myeloma: a retrospective cohort study
SSA positivity is associated with a higher risk of disease progression in MM patients, suggesting it may serve as a valuable prognostic marker. The relationship between autoantibodies and MM prognosis warrants further investigation in larger, multicenter studies to elucidate the underlying mechanisms and inform clinical management.
Authors
- Lin Zhou (ORCID: https://orcid.org/0000-0002-6428-7392)
- Hefei Ren (ORCID: https://orcid.org/0000-0003-0946-5683)
- Lei Chen (ORCID: https://orcid.org/0000-0003-3386-3702)
- Jiafeng Zhang (ORCID: https://orcid.org/0000-0001-9544-7785)
- Hongkun Wu
- Xin Wang (ORCID: https://orcid.org/0000-0002-5005-5814)
- Huiquan Wang
Institutions
- Shanghai Changzheng Hospital (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-02-21
- DOI
- https://doi.org/10.3389/fonc.2025.1529678
- Citations
- 1
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.77
Funders
- Shandong University
- National Natural Science Foundation of China
- Capital Medical University
- Science and Technology Commission of Shanghai Municipality